Home > Insider Trading > Filing (0000899243-18-025415)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1183765	Molecular Templates Inc.	MTEM	Pharmaceutical Preparations (2834)	943409596

Insiders

Cik	Name	Reported Address	Director	Officer	Large Shareholder	Other
1325713	Bruce Kovner	C/O Caxton Corporation, 731 Alexander Road, Building #2. Suite 500 Princeton NJ 08540	Yes	No	No	No
1388551	Caxton Corp	731 Alexander Road, Building #2, Suite 500 Princeton NJ 08540	Yes	No	No	No
1576081	Cdk Associates, L.l.c.	C/O Caxton Corporation, 731 Alexander Road, Building #2, Suite 500 Princeton NJ 08540	Yes	No	No	No
1576113	D Scott Morenstein	C/O Caxton Alternative Management Lp 1330 6Th Avenue, 20Th Floor New York NY 10019	Yes	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2018-09-25	545,454	$5.50	1,559,241	No	4	P	Indirect	By CDK Associates, L.L.C.

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Indirect	By CDK Associates, L.L.C.

Footnotes

These shares are held by CDK Associates, L.L.C. and may be deemed to be beneficially owned by (i) Scott Morenstein, a Managing Director of Caxton Alternative Management LP, the investment manager of CDK Associates, L.L.C., (ii) Caxton Corporation, the manager of CDK Associates, LLC and (iii) Bruce Kovner, the chairman and sole shareholder of Caxton Corporation. Scott Morenstein serves as a director of the Issuer. Caxton Corporation, Bruce Kovner and CDK Associates, L.L.C. may be considered directors by deputization due to their affiliation with Scott Morenstein. Each Reporting Person disclaims beneficial ownership of these shares except to the extent of its or his pecuniary interest, if any, therein, and this report shall not be deemed to be an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.